D.E. Shaw & Co’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.5M | Sell |
1,708,433
-143,786
| -8% | -$2.99M | 0.02% | 811 |
|
|
2025
Q4 | $39.6M | Sell |
1,852,219
-169,118
| -8% | -$3.47M | 0.02% | 831 |
|
|
2025
Q3 | $33.9M | Buy |
2,021,337
+443,575
| +28% | +$6.65M | 0.02% | 854 |
|
|
2025
Q2 | $22.6M | Sell |
1,577,762
-294,415
| -16% | -$4.04M | 0.02% | 962 |
|
|
2025
Q1 | $27.1M | Sell |
1,872,177
-271,319
| -13% | -$3.85M | 0.02% | 763 |
|
|
2024
Q4 | $28.1M | Sell |
2,143,496
-182,007
| -8% | -$2.51M | 0.02% | 839 |
|
|
2024
Q3 | $27M | Sell |
2,325,503
-138,357
| -6% | -$1.3M | 0.02% | 827 |
|
|
2024
Q2 | $18.6M | Buy |
2,463,860
+318,373
| +15% | +$2.63M | 0.02% | 932 |
|
|
2024
Q1 | $21.5M | Sell |
2,145,487
-94,860
| -4% | -$883K | 0.02% | 889 |
|
|
2023
Q4 | $20.8M | Buy |
2,240,347
+503,823
| +29% | +$5.21M | 0.02% | 894 |
|
|
2023
Q3 | $22.1M | Buy |
1,736,524
+7,375
| +0.4% | +$101K | 0.02% | 790 |
|
|
2023
Q2 | $24.6M | Buy |
1,729,149
+307,931
| +22% | +$4.32M | 0.03% | 769 |
|
|
2023
Q1 | $21.2M | Buy |
1,421,218
+417,317
| +42% | +$6.32M | 0.02% | 857 |
|
|
2022
Q4 | $14.9M | Sell |
1,003,901
-3,447
| -0.3% | -$56.2K | 0.02% | 1123 |
|
|
2022
Q3 | $16.6M | Buy |
1,007,348
+90,053
| +10% | +$1.81M | 0.02% | 973 |
|
|
2022
Q2 | $19.3M | Buy |
917,295
+53,344
| +6% | +$1.09M | 0.02% | 893 |
|
|
2022
Q1 | $20.3M | Buy |
863,951
+218,888
| +34% | +$5.36M | 0.02% | 1024 |
|
|
2021
Q4 | $17.6M | Buy |
645,063
+9,281
| +1% | +$248K | 0.01% | 1185 |
|
|
2021
Q3 | $18.1M | Sell |
635,782
-57,435
| -8% | -$1.75M | 0.02% | 1084 |
|
|
2021
Q2 | $20.9M | Buy |
693,217
+167,934
| +32% | +$4.96M | 0.02% | 995 |
|
|
2021
Q1 | $13.4M | Sell |
525,283
-380,400
| -42% | -$9.74M | 0.01% | 1180 |
|
|
2020
Q4 | $22.2M | Buy |
905,683
+17,881
| +2% | +$336K | 0.02% | 903 |
|
|
2020
Q3 | $14.5M | Sell |
887,802
-647,695
| -42% | -$12M | 0.01% | 1004 |
|
|
2020
Q2 | $26.3M | Sell |
1,535,497
-681,495
| -31% | -$10.1M | 0.03% | 643 |
|
|
2020
Q1 | $25.8M | Sell |
2,216,992
-843,661
| -28% | -$17.4M | 0.04% | 498 |
|
|
2019
Q4 | $85.1M | Sell |
3,060,653
-522,728
| -15% | -$13.1M | 0.1% | 238 |
|
|
2019
Q3 | $81.1M | Buy |
3,583,381
+581,554
| +19% | +$13.3M | 0.1% | 242 |
|
|
2019
Q2 | $75.7M | Buy |
3,001,827
+515,286
| +21% | +$13.8M | 0.09% | 261 |
|
|
2019
Q1 | $67.6M | Buy |
2,486,541
+1,215,631
| +96% | +$40.8M | 0.09% | 287 |
|
|
2018
Q4 | $41.9M | Buy |
1,270,910
+151,320
| +14% | +$6.08M | 0.06% | 403 |
|
|
2018
Q3 | $52.2M | Buy |
1,119,590
+205,918
| +23% | +$9.45M | 0.06% | 386 |
|
|
2018
Q2 | $39.5M | Buy |
913,672
+595,958
| +188% | +$28.6M | 0.05% | 446 |
|
|
2018
Q1 | $17.7M | Buy |
317,714
+259,812
| +449% | +$14.2M | 0.02% | 729 |
|
|
2017
Q4 | $3.09M | Sell |
57,902
-25,940
| -31% | -$1.22M | ﹤0.01% | 1825 |
|
|
2017
Q3 | $3.62M | Buy |
+83,842
| New | +$3.98M | 0.01% | 1616 |
|
|
2015
Q4 | – | Sell |
-16,913
| Closed | -$1.3M | – | 3914 |
|
|
2015
Q3 | $1.3M | Sell |
16,913
-26,887
| -61% | -$2.17M | ﹤0.01% | 2418 |
|
|
2015
Q2 | $3.25M | Sell |
43,800
-91,088
| -68% | -$6.56M | ﹤0.01% | 1809 |
|
|
2015
Q1 | $9.78M | Buy |
134,888
+112,816
| +511% | +$7.84M | 0.02% | 976 |
|
|
2014
Q4 | $1.46M | Sell |
22,072
-60,943
| -73% | -$3.72M | ﹤0.01% | 2532 |
|
|
2014
Q3 | $4.55M | Sell |
83,015
-292,223
| -78% | -$16.6M | 0.01% | 1632 |
|
|
2014
Q2 | $21.8M | Buy |
375,238
+242,181
| +182% | +$14.2M | 0.03% | 644 |
|
|
2014
Q1 | $8.25M | Sell |
133,057
-165,070
| -55% | -$9.6M | 0.01% | 1179 |
|
|
2013
Q4 | $15.9M | Buy |
298,127
+57,835
| +24% | +$3.1M | 0.02% | 825 |
|
|
2013
Q3 | $12.1M | Sell |
240,292
-83,592
| -26% | -$4.08M | 0.02% | 876 |
|
|
2013
Q2 | $14.8M | Buy |
+323,884
| New | +$14.5M | 0.03% | 657 |
|
Other funds holding MD
VPM
VCM
WA
D.E. Shaw & Co's MD Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Pediatrix Medical (MD) stake by 7.8% in Q1 2026, selling an estimated $2.99M and leaving 1,708,433 shares worth $36.5M. The position accounts for 0.02% of the portfolio, ranked #811.
D.E. Shaw & Co first reported a position in MD in Q2 2013 and has held it in 45 quarters since. The position peaked at $85.1M in Q4 2019. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- D.E. Shaw & Co held 1,708,433 shares of Pediatrix Medical worth $36.5M as of Q1 2026.
- D.E. Shaw & Co sold 143,786 Pediatrix Medical shares in Q1 2026, an estimated $2.99M.
- Pediatrix Medical made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #811 holding.
- D.E. Shaw & Co first reported a position in Pediatrix Medical in Q2 2013 and has held it in 45 quarters since.
- D.E. Shaw & Co's Pediatrix Medical position peaked at $85.1M in Q4 2019.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.